Veidekke ASA (0GF6)
London Exchange · UK · prices in NOK · close of 23 Oct 2026
Key indicators
| Last close | NOK 205.50 |
|---|---|
| 52-week range | 121.00 – 218.00 |
| Return, 1 month / 3 months | −4.8% / +9.7% |
| Return, 1 year / 3 years | +38.6% / +167.7% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 19.4% |
| Worst drawdown (1 year) | -8.0% |
| Average daily value traded | 0.80M NOK |
| Dividend yield | 5.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Veidekke ASA is a Norwegian construction and civil engineering group based in Oslo. It builds roads, bridges, tunnels and other infrastructure, constructs residential and commercial buildings, and produces asphalt and aggregates for its own projects and outside customers. Its clients include public authorities, property developers and private companies, mainly in Scandinavia. The company also carries out property development and offers related contracting services across its home markets.
The shares are listed on the London Exchange in UK under the code 0GF6, and the price on this page is in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Veidekke ASA (0GF6) trades on the London Exchange in UK. It last closed at NOK 205.50 on 23 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 141 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 38.6% and over the last three months it rose 9.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 80 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.9% | ||
| From 52-week high | -5.7% | ||
| Momentum | 81 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 9.7% | ||
| 6-month return | 18.8% | ||
| 12-month return, skipping the last month | 45.5% | ||
| Stability (higher is calmer) | 93 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 19.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -8.0% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.80M NOK | ||
| Zero-volume days | 1.7% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.5% |
|---|---|
| 1 month | −4.8% |
| 3 months | +9.7% |
| 6 months | +18.8% |
| 1 year | +38.6% |
| 3 years | +167.7% |
| 5 years | +147.7% |
Signals
| 50-day / 200-day average | 208.55 / 186.93 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 32.96 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | NOK 11.2500 |
| 8 May 2025 | NOK 9.0000 |
| 8 May 2024 | NOK 7.9000 |
| 11 May 2023 | NOK 7.7500 |
| 12 May 2022 | NOK 7.0000 |
| 6 May 2021 | NOK 5.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.